AbbVie Inc v. Genmab A/S

Court

District Court, W.D. Washington (W.D. Wash.)
Official Court Website →

Assigned judge

Tana Lin · 119 cases in index

Docket number

2:25-cv-00510

Cause

18:1836(b) - Civil Action to Protect Trade Secrets
18 U.S.C. § 1836

Nature of suit

880 Defend Trade Secrets Act (of 2016)
This group covers federal tax disputes and other statutory actions, including IRS-related suits and claims arising under various federal regulatory statutes.

Jurisdiction

Federal Question

Jury demand

Plaintiff

Date filed

03/21/2025

4,743 Federal Tax / Statutory Actions cases in this court are indexed here.

Parties

• plaintiff · AbbVie, Inc Pharmaceuticals & Biotechnology · 5032 cases
• defendant · Genmab A/S Pharmaceuticals & Biotechnology · 2 cases

About Federal Tax / Statutory Actions Lawsuits

This group covers federal tax disputes and other statutory actions, including IRS-related suits and claims arising under various federal regulatory statutes.

Frequently Asked Questions

What is AbbVie Inc v. Genmab A/S?

AbbVie Inc v. Genmab A/S is a federal federal tax / statutory actions lawsuit filed on 03/21/2025 in the District Court, W.D. Washington. The case is currently open in the federal court system. This group covers federal tax disputes and other statutory actions, including IRS-related suits and claims arising under various federal regulatory statutes.

What type of case is this?

It is classified as “Federal Tax / Statutory Actions” under the federal nature-of-suit system. This group covers federal tax disputes and other statutory actions, including IRS-related suits and claims arising under various federal regulatory statutes.

What court is the case in?

The case is in the District Court, W.D. Washington, docket number 2:25-cv-00510.

When was the case filed?

AbbVie Inc v. Genmab A/S was filed on 03/21/2025. The case is currently open.

What law is the case brought under?

The docket lists the cause as 18 U.S.C. § 1836.